Literature DB >> 24300419

Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways.

Timothy B Oriss1, Nandini Krishnamoorthy, Prabir Ray, Anuradha Ray.   

Abstract

PURPOSE OF REVIEW: Binding of the receptor tyrosine kinase, c-kit, to its ligand, stem cell factor (SCF), mediates numerous biological functions. Important roles for c-kit in hematopoiesis, melanogenesis, erythropoiesis, spermatogenesis, and carcinogenesis are well documented. Similarly, activation of mast cells and eosinophils by c-kit ligation has long been known to result in degranulation with concomitant release of pro-inflammatory mediators including cytokines. This review will highlight a recently discovered function of c-kit in regulating the adaptive immune responses with relevance to allergic diseases. RECENT
FINDINGS: Recent studies in a number of laboratories including our own highlight the previously unappreciated functions for c-kit in immunological processes. Increased expression of c-kit and its ligand, SCF, on dendritic cells by Th2/Th17-inducing stimuli leads to c-kit activation and immune skewing toward these subsets and away from Th1 responses. Treatment of dendritic cells with inhibitors of c-kit activation such as imatinib mesylate (Gleevec) induces breach of T-cell tolerance, skewing of responses toward Th1, and activation of natural killer cells.
SUMMARY: Taken together, these observations suggest that the c-kit/SCF axis may be a useful target for redirecting deleterious immune responses in various disease settings, including allergic diseases that are often associated with Th2 and Th17 responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24300419      PMCID: PMC4125121          DOI: 10.1097/ACI.0000000000000019

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  74 in total

1.  Role of IL-6 in directing the initial immune response to schistosome eggs.

Authors:  A C La Flamme; A S MacDonald; E J Pearce
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 3.  Signal transduction via the stem cell factor receptor/c-Kit.

Authors:  L Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

4.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant.

Authors:  J G Flanagan; D C Chan; P Leder
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

5.  Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells.

Authors:  Michelle B Bowie; David G Kent; Michael R Copley; Connie J Eaves
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

Review 6.  Hereditary anemias of the mouse: a review for geneticists.

Authors:  E S Russell
Journal:  Adv Genet       Date:  1979       Impact factor: 1.944

Review 7.  Stem cell factor: a hemopoietic cytokine with important targets in asthma.

Authors:  S H P Oliveira; N W Lukacs
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2003-12

8.  Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor.

Authors:  D Toksoz; K M Zsebo; K A Smith; S Hu; D Brankow; S V Suggs; F H Martin; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 9.  Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.

Authors:  Laurent Reber; Carla A Da Silva; Nelly Frossard
Journal:  Eur J Pharmacol       Date:  2006-02-17       Impact factor: 4.432

10.  Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.

Authors:  Christophe Borg; Magali Terme; Julien Taïeb; Cédric Ménard; Caroline Flament; Caroline Robert; Koji Maruyama; Hiro Wakasugi; Eric Angevin; Kris Thielemans; Axel Le Cesne; Véronique Chung-Scott; Vladimir Lazar; Isabelle Tchou; Florent Crépineau; François Lemoine; Jacky Bernard; Jonhantan A Fletcher; Ali Turhan; Jean-Yves Blay; Alain Spatz; Jean-François Emile; Michael C Heinrich; Salah Mécheri; Thomas Tursz; Laurence Zitvogel
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more
  14 in total

1.  Stem Cell Factor (SCF) is a putative biomarker of antidepressant response.

Authors:  Francesco Benedetti; Sara Poletti; Thomas A Hoogenboezem; Clara Locatelli; Oliver Ambrée; Harm de Wit; Annemarie J M Wijkhuijs; Elena Mazza; Chiara Bulgarelli; Benedetta Vai; Cristina Colombo; Enrico Smeraldi; Volker Arolt; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

2.  Pathways of impending disease flare in African-American systemic lupus erythematosus patients.

Authors:  Melissa E Munroe; Evan S Vista; Joan T Merrill; Joel M Guthridge; Virginia C Roberts; Judith A James
Journal:  J Autoimmun       Date:  2017-02-02       Impact factor: 7.094

Review 3.  KIT as a master regulator of the mast cell lineage.

Authors:  Mindy Tsai; Peter Valent; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2022-04-22       Impact factor: 14.290

Review 4.  Immunological off-target effects of imatinib.

Authors:  Laurence Zitvogel; Sylvie Rusakiewicz; Bertrand Routy; Maha Ayyoub; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2016-03-31       Impact factor: 66.675

Review 5.  A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.

Authors:  Maria Isabel Carvalho; Ricardo Silva-Carvalho; Isabel Pires; Justina Prada; Rodolfo Bianchini; Erika Jensen-Jarolim; Felisbina L Queiroga
Journal:  Biomed Res Int       Date:  2016-12-08       Impact factor: 3.411

6.  Cytochrome P450s in human immune cells regulate IL-22 and c-Kit via an AHR feedback loop.

Authors:  Renate Effner; Julia Hiller; Stefanie Eyerich; Claudia Traidl-Hoffmann; Knut Brockow; Massimo Triggiani; Heidrun Behrendt; Carsten B Schmidt-Weber; Jeroen T M Buters
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

Review 7.  Mast Cells: A New Frontier for Cancer Immunotherapy.

Authors:  Jake N Lichterman; Sangeetha M Reddy
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

8.  Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Marlene Dias; Justina Prada; Hugo Gregório; Luis Lobo; Felisbina Queiroga
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-05       Impact factor: 2.916

9.  Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.

Authors:  Isabel Gonçalves Silva; Bernhard F Gibbs; Marco Bardelli; Luca Varani; Vadim V Sumbayev
Journal:  Oncotarget       Date:  2015-10-20

Review 10.  Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?

Authors:  Xiaoyan Liu; Qing Zhou; Yan Xu; Minjiang Chen; Jing Zhao; Mengzhao Wang
Journal:  Oncotarget       Date:  2017-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.